100 QUESTIONS IN CARDIOLOGY

(Michael S) #1

7 How can I outline a management plan for the


patient with essential hypertension?


Aroon Hingorani


A management plan for the initial assessment, investigation and

follow up of a patient presenting with elevated blood pressure is

presented below.

INITIAL ASSESSMENT


  • Measure BP*

  • History (including drug and family history) and examination

  • Baseline screen for secondary causes of hypertension**:
    urinalysis, creatinine and electrolytes

  • Assessment of end-organ damage***:
    ECG, fundoscopy

  • Assessment of other cardiovascular risk factors:
    age, gender, BP, total and HDL-cholesterol
    ECG-LVH, diabetes, smoking status


INSTITUTE LIFESTYLE MODIFICATIONS


  • Salt(sodium restriction from 10g/d to 5g/d expect 5/3 mmHg reduction in BP)

  • Alcohol(change depends on amount consumed)

  • Weight(expect 1-2 mmHg BP reduction for every kg lost)

  • Aerobic exercise(4/3 mmHg reduction for thrice weekly aerobic exercise)

  • Smoking cessation(consider nicotine replacement)


COMPUTE CARDIOVASCULAR RISK

Use BP level and estimates of absolute and
relative cardiovascular disease risk
to guide:



  • Anti-hypertensive drug therapy
    initial treatment with thiazide diuretic or beta blocker unless contraindicated or not tolerated

  • Cholesterol lowering with statins
    consider aspirin


REVIEW


  • Adequacy of treatment: BP and cholesterol target

  • Side effects from treatment

  • Lifestyle modifications



  • Sitting position. Mean of 2-3 measurements over 4–6 weeks unless severity of BP dictates
    earlier treatment.
    ** Abnormalities identified from history, examination or baseline screen dictate further investi-
    gation to confirm/exclude renal parenchymal, renovascular, endocrine or other secondary
    causes of hypertension.
    * The presence of hypertensive retinopathy or LVH is an indication for BP lowering irrespective
    of the absolute BP level.
    **
    For references to risk calculators see Qu4, page 7.
    Reference: Vallance P. CME Cardiology II. Hypertension,J Roy Coll Phys Lon1999; 33 : 119-23

Free download pdf